Loading...

India-based health platform Lybrate raises USD3 mn

Image

12-Apr-17 Indian health tech startup Lybrate has raised USD3 mn in new funding to achieve its goal of connecting patients with doctors in India and helping to raise awareness of basic medical practices. The startup’s biggest rival is Practo, which offers doctor-finding and health information, and has also raised several million US dollars in past month.

Read More

Korean biotech firms are seen as undervalued by big investment firms

Image

10-Apr-17 Korean biotech companies are drawing much interest and investment from well-known foreign investors including Bain Capital, Goldman Sachs and the state-run Chinese company Tsinghua Tongfang Group. Korea biotech firms, according to one investor "are second to none, in terms of technology but their values have been underestimated due to the small size of the domestic market.” [image: Business Korea]

Read More

Dalian Wanda to invest USD10 bn in China healthcare hub

Image

10-Apr-17 Dalian Wanda Group will invest CNY70 bn (USD10 bn) in a health park in China's southwest, as some of the country's biggest companies look to tap demand for private healthcare. Wanda said it had signed an agreement with the Chengdu city government to create a 'park' with two international general hospitals, eight small specialized hospitals and 30 healthcare-related firms. [image: ET Healthword]

Read More

Gleneagles Global Hospitals launches a new facility in Bengaluru

Image

09-Apr-17 Gleneagles Global Hospitals, a Parkway Pantai Enterprise, has opened its newest facility in India, Richmond Road, spread over 15,000 sq ft, housing 10 core specialties with state-of-the-art equipment and diagnostics, offering multi-disciplinary care. Dr K Ravindranath, Chairman & Founder, said, “Our new hospital at Richmond Road is a significant addition to our ongoing efforts in medical excellence.” [image: ET Healthworld]

Read More

Zuellig Pharma invests in first innovation centre in Singapore

Image

05-Apr-17 Singapore based Zuellig Pharma has launched Zuellig Health Solutions innovation centre, in Singapore and plans to invest over USD35 mn in the next five years. On why it chose Singapore for its new venture, CEO John Davison said: "We see many of our clients in the pharmaceutical and consumer health sector (such as) GlaxoSmithKline and AstraZeneca here in Singapore." [image: Zuellig Pharma]

Read More
Share